Wound-healing spray moves to Phase III clinical trials

04/16/2013 | WTAJ-TV (Altoona, Pa.)

Patients are being recruited for Phase III clinical trials of a spray containing human cells that release growth factors into a wound to encourage tissue regeneration. Wounds treated with the spray were 52% more likely to heal than those treated with compression bandages in earlier trials.

View Full Article in:

WTAJ-TV (Altoona, Pa.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX